Literature DB >> 33245316

Second near-infrared photothermal materials for combinational nanotheranostics.

Cheng Xu1, Kanyi Pu.   

Abstract

Second near-infrared photothermal therapy (NIR-II PTT, 1000-1500 nm) has recently emerged as a new phototherapeutic modality with the advantages of deeper penetration, less energy dissipation and minimal normal-tissue toxicity over traditional first NIR PTT (750-1000 nm). However, suboptimal photothermal conversion and limited therapeutic efficacy remain the major challenges for NIR-II PTT. With the convergence in materials science, nanomedicine and biology, multifunctional NIR-II photothermal inorganic or organic materials have been extensively developed to combine NIR-II PTT with other therapeutic modalities for improved efficacies in treating life-threatening diseases including cancer and infection. This review summarizes the recent advances of NIR-II photothermal combinational theranostics pertinent to chemotherapy, immunotherapy, radiotherapy, and photodynamic, sonodynamic, chemodynamic, gene, gas, ionic, vascular and magnetothermal therapy. Potential obstacles and perspectives for future research and clinical translation of this new theranostic modality are also discussed.

Entities:  

Mesh:

Year:  2020        PMID: 33245316     DOI: 10.1039/d0cs00664e

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  41 in total

1.  [Photothermal effect of nano-copper sulfide against tongue squamous cell carcinoma].

Authors:  D Chen; Z Chen; Z Wang; Y Yang; Y Jiang; C Hu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-12-20

2.  Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy.

Authors:  Wenbo Han; Xiaopin Duan; Kaiyuan Ni; Youyou Li; Christina Chan; Wenbin Lin
Journal:  Biomaterials       Date:  2021-12-09       Impact factor: 12.479

3.  Long wavelength-emissive Ru(II) metallacycle-based photosensitizer assisting in vivo bacterial diagnosis and antibacterial treatment.

Authors:  Yuling Xu; Chonglu Li; Xin Ma; Wei Tuo; Le Tu; Xiaopeng Li; Yan Sun; Peter J Stang; Yao Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-01       Impact factor: 12.779

Review 4.  Recent advances in chiral nanomaterials with unique electric and magnetic properties.

Authors:  Junyoung Kwon; Won Jin Choi; Uichang Jeong; Wookjin Jung; Inkook Hwang; Ki Hyun Park; Seowoo Genevieve Ko; Sung Min Park; Nicholas A Kotov; Jihyeon Yeom
Journal:  Nano Converg       Date:  2022-07-18

5.  Tunable Color-Variable Solar Absorber Based on Phase Change Material Sb2Se3.

Authors:  Xin Li; Mingyu Luo; Xinpeng Jiang; Shishang Luo; Junbo Yang
Journal:  Nanomaterials (Basel)       Date:  2022-06-02       Impact factor: 5.719

6.  Transforming Commercial Copper Sulfide into Injectable Hydrogels for Local Photothermal Therapy.

Authors:  Xiaoran Wang; Zizhen Yang; Zhaowei Meng; Shao-Kai Sun
Journal:  Gels       Date:  2022-05-20

7.  A novel cascaded energy conversion system inducing efficient and precise cancer therapy.

Authors:  Yong Kang; Na Kong; Meitong Ou; Ying Wang; Qicai Xiao; Lin Mei; Bing Liu; Liqun Chen; Xiaobin Zeng; Xiaoyuan Ji
Journal:  Bioact Mater       Date:  2022-07-12

Review 8.  Recent Development of Polydopamine Anti-Bacterial Nanomaterials.

Authors:  Zhengwei Xu; Tingting Wang; Junqiu Liu
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 9.  Conjugated polymer nanoparticles and their nanohybrids as smart photoluminescent and photoresponsive material for biosensing, imaging, and theranostics.

Authors:  Xi Chen; Sameer Hussain; Ansar Abbas; Yi Hao; Akhtar H Malik; Xuemeng Tian; Huijia Song; Ruixia Gao
Journal:  Mikrochim Acta       Date:  2022-02-03       Impact factor: 5.833

10.  Construction of emissive ruthenium(II) metallacycle over 1000 nm wavelength for in vivo biomedical applications.

Authors:  Yuling Xu; Chonglu Li; Shuai Lu; Zhizheng Wang; Shuang Liu; Xiujun Yu; Xiaopeng Li; Yao Sun
Journal:  Nat Commun       Date:  2022-04-14       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.